Association Between D-Dimer Level with Clinical Severity and Radiological Imaging of Confirmed COVID-19 Patients at RSUP Dr. M. Djamil Padang

Hafis Herdiman, Masrul Basyar, Oea Khairsyaf

Abstract


Background: D-dimer could be used as a biomarker to distinguish the severity of COVID-19. High D-Dimer levels are associated with increased clinical severity and poor radiological imaging. This study aims to identify the correlation between D-dimer levels with clinical severity and radiological features of confirmed COVID-19 patients at RSUP dr. M. Djamil Padang.

Methods: This was a cross sectional study of 202 COVID-19 confirmed patients at RSUP dr. M. Djamil Padang using medical record data from 1 January to 31 March 2021. The data were collected using convenience sampling technique and analyzed by Kruskal Wallis Test to determine the association between D-dimer levels with clinical severity and radiological features.

Results: Majority of patients were in age groups of below 50 and 50-59 years, with equal proportion between men and women, and were in moderate clinical severity (58,4%). Most radiological imaging was in severe degree of 91 patients (45%). The association between D-dimer levels and clinical degree of COVID-19 patients as well as the association between D-dimer levels and severity of radiological imaging of COVID-19 patients were statistically significant (P=0.0001).

Conclusion: Elevated D-dimer level was a common feature at COVID-19 confirmed patients. High levels of D-dimer were associated with increased clinical severity and severe radiological features in COVID-19 patients.


Keywords


clinical severity of COVID-19, D-dimer, radiological imaging of COVID-19

Full Text:

PDF

References


dos Santos WG. Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomed Pharmacother. 2020;129.

World Health Organization. Coronavirus (COVID-19) [Internet]. World Health Organization. 2021 [cited 2021 Jan 16]. Available from: https://covid19.who.int/

He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Scientific Reports. 2021;11(1):1–7.

Ozen M, Yilmaz A, Cakmak V, Beyoglu R, Oskay A, Seyit M, et al. D-Dimer as a potential biomarker for disease severity in COVID-19. Am J Emerg Med. 2021;40:55–9.

Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):6808–17.

Vidali S, Morosetti D, Cossu E, Luisa M, Luisi E, Pancani S, et al. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res. 2020;6(2):00260–2020.

Yasin R, Gouda W. Chest X-ray findings monitoring COVID-19 disease course and severity. Egyptian Journal of Radiology and Nuclear Medicine. 2020;51(1):1–18.

Pascarella G, Strumia A, Piliego C, Bruno F, del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206.

Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac. 2021;9:100108.

Viradanti T, Kusmala YY. The relation between -dimer level and chest x-ray (CXR) scoring in COVID-19 patients: What we can learn from? In: Proceedings of the 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on “Emergency Preparedness and Disaster Response during COVID 19 Pandemic” (ASMC 2021). 2021. p. 149–52.

Yu HH, Qin C, Chen M, Wang W, Tian DS. D-dimer level is associated with the severity of COVID-19. Thromb Res. 2020;195:219–25.

Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, et al. D-Dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. Biomed Res Int. 2020;2020:6159720.

Wen S, Prasad A, Freeland K, Podury S, Patel J, Subedi R, et al. Clinical characteristics and outcomes of COVID-19 in west virginia. Viruses. 2021;13(5):835.

Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19(7):e13168.

García-Alvarado FJ, Muñoz-Hernández MA, Moran Guel E, González-Martínez MDR, MacÍas Corral MA, Delgado-Aguirre HA. Risk factors and clinical phenotypes associated with severity in patients with COVID-19 in northeast mexico. Vector Borne Zoonotic Dis. 2021;21(9):720–6.

Aydogan Eroglu S, Cagavi Z, Yildiz T, Karakurt Z, Interest Group O behalf of C. Can the usage of the chest x-ray scoring during hospitalization in patients with COVID-19 predict the severity of the disease? Turk Thorac J. 2021;22(3):190–8.

Setiawati R, Widyoningroem A, Handarini T, Hayati F, Basja AT, Surya ARD, et al. Modified chest x-ray scoring system in evaluating severity of COVID-19 patient in Dr. Soetomo General Hospital Surabaya, Indonesia. Int J Gen Med. 2021;14:2407–12.

Baratella E, Crivelli P, Marrocchio C, Bozzato AM, de Vito A, Madeddu G, et al. Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data. J Bras Pneumol. 2020;46(5):1–8.

Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020;50(3):548–57.

Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15–27.

Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8(1):1–11.

Gungor B, Atici A, Baycan OF, Alici G, Ozturk F, Tugrul S, et al. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am J Emerg Med. 2021;39:173–9.

Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic value of D-Dimer in COVID-19: A meta-analysis and meta-regression. Clin Appl Thromb Hemost. 2021;27:10760296211010976.

Mahardhika GS, Dharma Tedjamartono T, Buwono PW. High D-dimer and CRP levels in an asymptomatic COVID-19 patient: A case report and brief literature review. Seminar Nasional Riset Kedokteran. 2021;2:167–77.

Zhao R, Su Z, Komissarov AA, Liu SL, Yi G, Idell S, et al. Associations of D-Dimer on admission and clinical features of COVID-19 patients: A systematic review, meta-analysis, and meta-regression. Front Immunol. 2021;12:691249.




DOI: https://doi.org/10.36497/jri.v42i4.241

Refbacks

  • There are currently no refbacks.




Copyright (c) 2022 Jurnal Respirologi Indonesia

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter